The Biomedical Sciences sector contributes about 18% of the country's manufacturing output. Singapore currently hosts six of the top ten pharmaceutical conglomerates, key industry players and a growing base of medical technology companies within Tuas Biomedical Park, a 183-hectare BMS-dedicated site slated for expansion to double its current capacity due to increasing industry demand. Singapore's Economic Development Board, A*STAR and Bio*One Capital are working in close partnership to further develop Singapore's biomedical sciences cluster.
- Manufacturing including Bioprocessing,
- Chemical Engineering,Pharmaceutical Formulation
- R&D including Bioinformatics,
- Clinical Research, Computational,
- Biomedical Engineering, Biostatictis,
- Biology, Medicinal Chemistry,
- Molecular & Cell Biology
- Applied Biosystems
- Eli Lilly
- ES Cell International
- Glaxo SmithKline
- Johns Hopkins
- Merlion & more…
Disclaimer: The data provided here is based on the facts and research using available sources. As the data is made available on "as is" basis and subject to change anytime. This website shall not be liable for any discrepancy found in the data on our site and actual figures.